Author:
Mikamo Hiroshige,Matsumizu Miyako,Nakazuru Yoshiomi,Nagashima Masahito
Subject
Infectious Diseases,Pharmacology (medical),Microbiology (medical)
Reference31 articles.
1. The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections;Cosar;Ann Inst Pasteur,1959
2. A therapeutic review and update;Freeman;Drugs,1997
3. Why metronidazole is active against both bacteria and parasites;Samuelson;Antimicrob Agents Chemother,1999
4. Comparing the reduction of nitroimidazoles in bacteria and mammalian tissues and relating it to biological activity;Goldman;Biochem Pharmacol,1986
5. In vitro antimicrobial activity of razupenem (SMP-601, PTZ601) against anaerobic bacteria;Tran;Antimicrob Agents Chemother,2011
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A randomized, double-blind, positive-controlled, Phase-II clinical trial to evaluate efficacy and safety of Fuke Qianjin capsule in Pakistani patients with pelvic inflammatory disease;Frontiers in Pharmacology;2024-03-22
2. Updates on the Causes, Diagnosis, and Management of Peritoneal Abscesses: A Systematic Review;Cureus;2023-11-10
3. Acute malignant colorectal obstruction (K56.6; C18, C19, C20), adults;Koloproktologia;2023-06-03
4. Effectiveness and safety of morinidazole in the treatment of pelvic inflammatory disease: A multicenter, prospective, open-label phase IV trial;Frontiers in Medicine;2022-08-03
5. Intra‐abdominal abscess with
Prevotella
species and
Streptococcus anginosus
co‐infection in a peritoneal dialysis patient;Nephrology;2019-07-25